Viking Therapeutics (VKTX) Misses Q3 EPS by 11c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.81), $0.11 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
• Italy's Meloni seeks to normalize US relations after Trump spat